A progression of Stargardt disease can assess autofluorescence over a 12-month clinical research study.
Researchers at the Institute of Molecular and Clinical Ophthalmology Basel, Switzerland (a consortium led by the ProgStar Study Group) have reported that autofluorescence imaging in… Read More »A progression of Stargardt disease can assess autofluorescence over a 12-month clinical research study.